98% Pharmaceutical Raw Materials Oxaliplatin CAS 61825-94-3 for Antineoplastic

• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP, BP, SGS
• Suitable for: Elderly, Children, Adult
• State: White Powder
• Purity: >98%
• Model NO.: Frazer-Oxaliplatin
• CAS No.: 61825-94-3
• Test Method: HPLC
• MOQ: 1kg
• Appearance: White Powder
• Shelf Life: 2 Years
• Storage: Cool Dry Place
• Delivery: Express 5-7 Days Arrive
• Sample: Available
• Application: Pharmaceutical Grade
• Molecular Weight: 395.28
• Transport Package: Foil Bag
• Specification: 1kg Per Foil Bag, 10 Bags Per Carton, 25 Kg Per Dr
• Trademark: Frazer
• Origin: China
• Production Capacity: 1000kg/Month

Product Description

98% Pharmaceutical Raw Materials Oxaliplatin CAS 61825-94-3 for Antineoplastic

 

Product Name	98% Pharmaceutical Raw Materials Oxaliplatin CAS 61825-94-3 for Antineoplastic
Appearance	White powder
Molecular formula	C8h14n2o4PT
Molecular Weight	397.29
Keywords	Pharmaceutical Oxaliplatin Raw Materials Oxaliplatin powder;Oxaliplatin
Shelf Life	24 months when properly stored
Storage	Keep in a cool, dry, dark location

 

What is Oxaliplatin? Oxaliplatin injection is given along with other medicines to treat advanced cancer of the colon or rectum. It is also used to treat severe colon cancer in patients who have had a surgery.

Function of Oxaliplatin

Anti-tumor drugs; pharmaceutical raw materials for anti-cancer; scientific research reagents; raw materials; small molecule inhibitors; medical raw materials; intermediates; chemical raw materials

Application of Oxaliplatin

Oxaliplatin, also called Eloxatin or Eloxatine, is a platinum derivative.
Used clinically to treat patients with metastatic colorectal cancer after failure of fluorouracil treatment, can be used alone or in combination with 5-fluorouracil. It is the third-generation platinum antitumor compound after cisplatin and carboplatin, and so far the only platinum-based drug with significant effectiveness against colorectal cancer. It also inhibits proliferation of ovarian cancer and melanoma cell lines.